A retinoid acid 'resistant' t(15;17) acute promyelocytic leukemia cell line: isolation, morphological, immunological, and molecular features - PubMed (original) (raw)
Affiliations
- PMID: 1453773
A retinoid acid 'resistant' t(15;17) acute promyelocytic leukemia cell line: isolation, morphological, immunological, and molecular features
E Duprez et al. Leukemia. 1992 Dec.
Abstract
We report the isolation of a maturation-resistant acute promyelocytic leukemia (APL) cell line. This permanent cell line, derived from the same patient as the maturation inducible NB4 cell line, is the first retinoid-resistant cell line with a t(15;17) chromosomal translocation. Morphological, immunocytochemical and molecular features of the maturation responsive (NB4) and unresponsive (NB4-RAr) cells are compared. The isolation of the NB4-RAr cell line occurred through a two-step process requiring the continuous selective pressure of all-trans-retinoic acid. Cells are also resistant to 13-cis-retinoic acid. Karyotypic and Southern-blot analyses show that the two cell lines are similar with respect to the translocation. Northern-blot analyses show that the chimeric fusion transcript PML-RAR alpha and the normal allelic PML and RAR alpha transcripts are similarly expressed in both cell lines. The molecular basis for unresponsiveness to retinoic acid is not known. This resistant cell line offers a cellular model for molecular biology studies on the mechanism of induction of APL cell maturation, as well as a means to elucidate the molecular mechanisms of resistance. It also furnishes a unique tool for designing and/or screening new therapeutic drugs to avoid or relieve retinoid maturation blockage.
Similar articles
- Molecular cytogenetics of the acute promyelocytic leukemia-derived cell line NB4 and of four all-trans retinoic acid-resistant subclones.
Mozziconacci MJ, Rosenauer A, Restouin A, Fanelli M, Shao W, Fernandez F, Toiron Y, Viscardi J, Gambacorti-Passerini C, Miller WH Jr, Lafage-Pochitaloff M. Mozziconacci MJ, et al. Genes Chromosomes Cancer. 2002 Nov;35(3):261-70. doi: 10.1002/gcc.10117. Genes Chromosomes Cancer. 2002. PMID: 12353268 - Characterization of the PML-RAR alpha chimeric product of the acute promyelocytic leukemia-specific t(15;17) translocation.
Nervi C, Poindexter EC, Grignani F, Pandolfi PP, Lo Coco F, Avvisati G, Pelicci PG, Jetten AM. Nervi C, et al. Cancer Res. 1992 Jul 1;52(13):3687-92. Cancer Res. 1992. PMID: 1319828 - Retinoic acid receptors: involvement in acute promyelocytic leukemia.
Agadir A, Cornic M, Gourmel B, Lefebvre P, Degos L, Chomienne C. Agadir A, et al. Cell Mol Biol (Noisy-le-grand). 1994 May;40(3):263-74. Cell Mol Biol (Noisy-le-grand). 1994. PMID: 7920173 Review. - Retinoic acid and acute promyelocytic leukemia: a model of targetting treatment for human cancer.
Chen Z, Chen SJ, Wang ZY. Chen Z, et al. C R Acad Sci III. 1994 Dec;317(12):1135-41. C R Acad Sci III. 1994. PMID: 7697468 Review.
Cited by
- Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research.
Skopek R, Palusińska M, Kaczor-Keller K, Pingwara R, Papierniak-Wyglądała A, Schenk T, Lewicki S, Zelent A, Szymański Ł. Skopek R, et al. Int J Mol Sci. 2023 Mar 11;24(6):5377. doi: 10.3390/ijms24065377. Int J Mol Sci. 2023. PMID: 36982453 Free PMC article. Review. - Caspase-9-mediated cleavage of vimentin attenuates the aggressiveness of leukemic NB4 cells.
Hakim F, Kazemiraad C, Akbari-Birgani S, Abdollahpour D, Mohammadi S. Hakim F, et al. Mol Cell Biochem. 2023 Nov;478(11):2435-2444. doi: 10.1007/s11010-023-04671-w. Epub 2023 Feb 18. Mol Cell Biochem. 2023. PMID: 36807844 - A bavachinin analog, D36, induces cell death by targeting both autophagy and apoptosis pathway in acute myeloid leukemia cells.
Zhang W, Liu J, Li Y, Guo F. Zhang W, et al. Cancer Chemother Pharmacol. 2022 Sep;90(3):251-265. doi: 10.1007/s00280-022-04462-y. Epub 2022 Aug 12. Cancer Chemother Pharmacol. 2022. PMID: 35960342 - Complex context relationships between DNA methylation and accessibility, histone marks, and hTERT gene expression in acute promyelocytic leukemia cells: perspectives for all-trans retinoic acid in cancer therapy.
Garsuault D, Bouyer C, Nguyen E, Kandhari R, Prochazkova-Carlotti M, Chevret E, Forgez P, Ségal-Bendirdjian E. Garsuault D, et al. Mol Oncol. 2020 Jun;14(6):1310-1326. doi: 10.1002/1878-0261.12681. Epub 2020 Apr 22. Mol Oncol. 2020. PMID: 32239597 Free PMC article. - _N_-Glycosylation of Lipocalin 2 Is Not Required for Secretion or Exosome Targeting.
Borkham-Kamphorst E, Van de Leur E, Meurer SK, Buhl EM, Weiskirchen R. Borkham-Kamphorst E, et al. Front Pharmacol. 2018 Apr 25;9:426. doi: 10.3389/fphar.2018.00426. eCollection 2018. Front Pharmacol. 2018. PMID: 29755357 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials